Literature DB >> 18438721

Managing dual use technology: it takes two to tango.

Lalit Kant1, D T Mourya.   

Abstract

Like nuclear energy, most technologies could have dual use-for health and well being and disaster and terror. Some research publications have brought to the forefront the tragic consequences of the latter potential through their possible use. Monitoring life science research and development (R&D) to prevent possible misuse is a challenging task globally, more so in developing economies like India, which are emerging as major biotech hubs. As a signatory to the Biological and Toxin Weapons Convention, India has put in motion a process of evolving a series of measures to manage dual-use technology. The Indian Council of Medical Research (ICMR) has taken a lead in drafting model codes of conduct, ethics and practice for use by other S&T agencies to tailor them as per their requirements. Taking cue from the discussions held by the editors of the various medical and science journals in the developed world, the Indian Journal of Medical Research, the official publication of the ICMR, is working on policy and uniform practice of publication of dual-use research results. The Government of India too has promulgated legal provisions to minimize the risks of misuse of technology, like the Weapons of Mass Destruction Act. Clearly, no single agency would be able to manage the dual-use of technology effectively. Multiple agencies have to come together to work in tandem for effective implementation of various measure and also like Janus, ensure that they are neither too restrictive nor intrusive to discourage the development of science.

Mesh:

Year:  2008        PMID: 18438721     DOI: 10.1007/s11948-008-9062-9

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  9 in total

1.  Statement on the consideration of biodefence and biosecurity.

Authors:  Ronald Atlas; Philip Campbell; Nicholas R Cozzarelli; Greg Curfman; Lynn Enquist; Gerald Fink; Annette Flanagin; Jacqueline Fletcher; Elizabeth George; Gordon Hammes; David Heyman; Thomas Inglesby; Samuel Kaplan; Donald Kennedy; Judith Krug; Rachel Levinson; Emilie Marcus; Henry Metzger; Stephen S Morse; Alison O'Brien; Andrew Onderdonk; George Poste; Beatrice Renault; Robert Rich; Ariella Rosengard; Steven Salzberg; Mary Scanlan; Thomas Shenk; Herbert Tabor; Harold Varmus; Eckard Wimmer; Keith Yamamoto
Journal:  Nature       Date:  2003-02-15       Impact factor: 49.962

2.  Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.

Authors:  Jeronimo Cello; Aniko V Paul; Eckard Wimmer
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

3.  The structure and receptor binding properties of the 1918 influenza hemagglutinin.

Authors:  S J Gamblin; L F Haire; R J Russell; D J Stevens; B Xiao; Y Ha; N Vasisht; D A Steinhauer; R S Daniels; A Elliot; D C Wiley; J J Skehel
Journal:  Science       Date:  2004-02-05       Impact factor: 47.728

4.  Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk.

Authors:  Lawrence M Wein; Yifan Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-28       Impact factor: 11.205

5.  Biotech boom.

Authors:  K S Jayaraman
Journal:  Nature       Date:  2005-07-28       Impact factor: 49.962

6.  Bioterror and "bioart"--a plague o' both your houses.

Authors:  George J Annas
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

7.  Publish no evil : should editors publish research that could have dual-use?

Authors:  Lalit Kant
Journal:  Indian J Med Res       Date:  2006-02       Impact factor: 2.375

8.  India's health biotech sector at a crossroads.

Authors:  Sarah E Frew; Rahim Rezaie; Stephen M Sammut; Monali Ray; Abdallah S Daar; Peter A Singer
Journal:  Nat Biotechnol       Date:  2007-04       Impact factor: 54.908

9.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

  9 in total
  2 in total

1.  The 'Magic Light': A Discussion on Laser Ethics.

Authors:  Andreas Stylianou; Michael A Talias
Journal:  Sci Eng Ethics       Date:  2014-06-11       Impact factor: 3.525

2.  Establishment of Biosafety Level-3 (BSL-3) laboratory: important criteria to consider while designing, constructing, commissioning & operating the facility in Indian setting.

Authors:  Devendra T Mourya; Pragya D Yadav; Triparna Dutta Majumdar; Devendra S Chauhan; Vishwa Mohan Katoch
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.